I 
114TH CONGRESS 
2D SESSION 
H. R. 5492 
To support programs for mosquito-borne and other vector-borne disease 
surveillance and control. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 15, 2016 
Mr. MURPHY of Florida (for himself and Mr. CLAWSON of Florida) introduced 
the following bill; which was referred to the Committee on Energy and 
Commerce 
A BILL 
To support programs for mosquito-borne and other vector- 
borne disease surveillance and control. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Strengthening Mos-
quito Abatement for Safety and Health Act’’ or the 
‘‘SMASH Act’’. 
SEC. 2. REAUTHORIZATION OF MOSQUITO ABATEMENT FOR 
SAFETY AND HEALTH PROGRAM. 
Section 317S of the Public Health Service Act (42 
U.S.C. 247b–21) is amended— 
VerDate Sep 11 2014 
03:28 Jun 16, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5492.IH
H5492
SSpencer on DSK4SPTVN1PROD with BILLS
(ii) in subparagraph (D), by inserting 
‘‘or that demonstrates to the Secretary 
that the control program is consistent with 
existing State mosquito control plans, or 
policies, or other applicable State pre-
paredness plans’’ before the period at the 
end; 
(C) in paragraph (4)(C), by striking ‘‘that 
extraordinary’’ and all that follows through the 
period at the end and inserting ‘‘that— 
‘‘(i) extraordinary economic conditions 
in the political subdivision or consortium of 
political subdivisions involved justify the 
waiver; or 
‘‘(ii) the geographical area covered by 
a political subdivision or consortium for a 
grant under paragraph (1) has an extreme 
need due to— 
‘‘(I) the size or density of the 
human population; 
‘‘(II) the size or density of the 
mosquito population; or 
‘‘(III) the severity of the mos-
quito-borne disease, such that ex-
pected serious adverse health out-
VerDate Sep 11 2014 
03:28 Jun 16, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5492.IH
H5492
SSpencer on DSK4SPTVN1PROD with BILLS
comes for the human population jus-
tify the waiver.’’; and 
(D) by amending paragraph (6) to read as 
follows: 
‘‘(6) NUMBER OF GRANTS.—A political subdivi-
sion or a consortium of political subdivisions may 
not receive more than one grant under paragraph 
(1).’’; and 
(3) in subsection (f)— 
(A) 
in 
paragraph 
(1), 
by 
striking 
‘‘$100,000,000 for fiscal year 2003, and such 
sums as may be necessary for each of fiscal 
years 2004 through 2007’’ and inserting 
‘‘$130,000,000 for each of fiscal years 2016 
through 2021’’; 
(B) in paragraph (2), by striking ‘‘the 
Public Health Security and Bioterrorism Pre-
paredness and Response Act of 2002’’ and in-
serting ‘‘other medical and public health pre-
paredness and response laws’’; and 
(C) in paragraph (3)— 
(i) in the heading, by striking ‘‘2004’’ 
and inserting ‘‘2017’’; and 
(ii) by striking ‘‘2004’’ and inserting 
‘‘2017’’. 
VerDate Sep 11 2014 
03:28 Jun 16, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5492.IH
H5492
SSpencer on DSK4SPTVN1PROD with BILLS
SEC. 3. EPIDEMIOLOGY-LABORATORY CAPACITY GRANTS. 
Section 2821 of the Public Health Service Act (42 
U.S.C. 300hh–31) is amended— 
(1) in subsection (a)(1), by inserting ‘‘, includ-
ing mosquito and other vector-borne diseases,’’ after 
‘‘infectious diseases’’; and 
(2) in subsection (b), by striking ‘‘2010 through 
2013’’ and inserting ‘‘2016 through 2021’’. 
SEC. 4. GAO STUDY. 
(a) STUDY.—The Comptroller General of the United 
States shall conduct a study on the state of surveillance 
and control of mosquito-borne infectious diseases in the 
United States and territories, including the state of pre-
paredness for conducting such surveillance and control. 
The study shall include— 
(1) a description of the infrastructure and pro-
grams for mosquito control in the United States, in-
cluding— 
(A) how such infrastructure and programs 
are organized and implemented at the Federal, 
State and local levels, including with respect to 
departments and agencies of the States, and 
local organizations (including special districts) 
involved in such control programs; 
(B) the role of the private sector in such 
activities; 
VerDate Sep 11 2014 
03:28 Jun 16, 2016
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5492.IH
H5492
SSpencer on DSK4SPTVN1PROD with BILLS
(C) how the authority for mosquito control 
impacts such activities; and 
(D) the resources for such infrastructure 
and programs, including Federal, State, and 
local funding sources; 
(2) how mosquito and other vector-borne dis-
ease surveillance and control is integrated into Fed-
eral, State, and local preparedness plans and ac-
tions, including how zoonotic surveillance is inte-
grated into infectious disease surveillance to support 
real-time situational surveillance and awareness; 
(3) Federal, State, and local laboratory capacity 
for emerging vector-borne diseases, including mos-
quito-borne and other zoonotic diseases; and 
(4) any regulatory challenges for developing and 
utilizing vector-control technologies and platforms as 
part of mosquito control strategies. 
(b) CONSULTATIONS.—In conducting the study under 
subsection (a), the Comptroller General of the United 
States shall consult with— 
(1) State and local public health officials in-
volved in mosquito and other vector-borne disease 
surveillance and control efforts; 
(2) researchers and manufacturers of mosquito 
control products; 
VerDate Sep 11 2014 
03:28 Jun 16, 2016
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5492.IH
H5492
SSpencer on DSK4SPTVN1PROD with BILLS
(3) stakeholders involved in mosquito abate-
ment activities; 
(4) infectious disease experts; and 
(5) entomologists involved in mosquito-borne 
disease surveillance and control efforts. 
(c) REPORT.—Not later than 18 months after the 
date of enactment of this Act, the Comptroller General 
of the United States shall submit to the Committee on 
Health, Education, Labor, and Pensions of the Senate and 
the Committee on Energy and Commerce of the House 
of Representatives a report containing the results of the 
study conducted under subsection (a) and relevant rec-
ommendations for Zika virus and other mosquito-borne 
diseases preparedness and response efforts. 
Æ 
VerDate Sep 11 2014 
03:28 Jun 16, 2016
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H5492.IH
H5492
SSpencer on DSK4SPTVN1PROD with BILLS